11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
Posts Tagged ‘NASDAQ:DNLI’
Jeff Bezos Investments in 2025: 12 Companies Bezos Is Investing In
Since leaving his position as CEO of Amazon in 2021, Jeff Bezos has been quite active.
12 Biotech Stocks with the Biggest Upside Potential
While 2024 was a "challenging" year for biotech stocks, JPMorgan is of the view that some names in the industry may be poised for considerable upside in the coming months.
8 Stocks Jeff Bezos is Buying
Jeff Bezos is a name closely tied to Amazon the company he reportedly founded in 1994 during a cross-country road trip.
40 Cities with the Lowest Life Expectancy in the US
In this article, we look at 40 cities with the lowest life expectancy in the US.
40 Cities with the Highest Life Expectancy in the US
In this article, we look at 40 Cities With The Highest Life Expectancy In The US.
5 Most Promising Biotech Stocks to Buy According to Analysts
In this article, we will take a look at the 5 most promising biotech stocks to buy according to analysts.
5 Biotech Stocks with Biggest Upside
In this article, we discuss 5 biotech stocks with biggest upside.
Jeff Bezos Stock Portfolio: 5 Companies and Startups
In this piece, we will take a look at the Jeff Bezos Stock Portfolio: 5 Companies and Startups.
Is Denali Therapeutics (DNLI) A Smart Long-Term Investment?
Baron Funds, an asset management firm, published its “Baron Growth Fund” fourth quarter 2021 investor letter – a copy of which can be downloaded here.
Do Hedge Funds Love Denali Therapeutics Inc. (DNLI)?
In this article we are going to use hedge fund sentiment as a tool and determine whether Denali Therapeutics Inc. (NASDAQ:DNLI) is a good investment right now.
Should You Now Liquidate Your Denali Therapeutics (DNLI) Position?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” third quarter 2021 investor letter – a copy of which can be downloaded here.
5 Pharmaceutical Stocks to Buy According to Jim Simons’ Euclidean Capital
Below is the list of 5 pharmaceutical stocks to buy according to Jim Simons’ Euclidean Capital.
Here is What Hedge Funds Think About Denali Therapeutics Inc. (DNLI)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
8 Best Stocks to Buy According to Billionaire Nicholas J. Pritzker’s Tao Capital
In this article, we will be discussing 8 best stocks to buy according to billionaire Nicholas J. Pritzker based on his hedge fund's Q1 portfolio.
5 Best Pharma and Biotech Stocks to Buy According to Jim Simons’ Euclidean Capital
In this article, we discuss the 5 best pharma and biotech stocks to buy according to Jim Simons' Euclidean Capital.
Where Do Hedge Funds Stand On Denali Therapeutics Inc. (DNLI)?
In this article we will check out the progression of hedge fund sentiment towards Denali Therapeutics Inc.
10 Best Pharmaceutical Stocks to Buy According to Billionaire Kerr Neilson
In this article we will take a look at the 10 best pharmaceutical stocks to buy according to billionaire Kerr Neilson.
Is Denali Therapeutics Inc. (DNLI) A Smart Long-Term Buy?
Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.
Is Denali Therapeutics (DNLI) A Smart Long-Term Buy?
Artisan Partners Limited Partnership, a high value-added investment management firm, published its ‘Artisan Small Cap Fund’ fourth quarter 2020 investor letter – a copy ...
Hedge Funds Are Crazy About Denali Therapeutics Inc. (DNLI)
The latest 13F reporting period has come and gone, and Insider Monkey have plowed through 823 13F filings that hedge funds and well-known value investors are required to file ...
25 Easiest Trivia Questions For Seniors With Dementia
Dementia is a terrible disease, but these 25 easiest trivia questions for seniors with dementia will perhaps provide a bright spark in the day for anyone afflicted with the illness...
Hedge Funds Have Never Been This Bullish On Denali Therapeutics Inc. (DNLI)
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.
Denali Therapeutics Inc. (DNLI): Are Hedge Funds Right About This Stock?
We hate to say this but, we told you so.
Denali Therapeutics Inc. (DNLI): Are Hedge Funds Right About This Stock?
At Insider Monkey, we pore over the filings of nearly 750 top investment firms every quarter, a process we have now completed for the latest reporting period.
Were Hedge Funds Right About Ditching Denali Therapeutics Inc. (DNLI)?
The first quarter was a breeze as Powell pivoted, and China seemed eager to reach a deal with Trump.
Hedge Funds Have Never Been This Bullish On Denali Therapeutics Inc. (DNLI)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Here’s What Hedge Funds Think About Denali Therapeutics Inc. (DNLI)
After several tireless days we have finished crunching the numbers from nearly 750 13F filings issued by the elite hedge funds and other investment firms that we track at Insider...
